REVB
Price
$2.73
Change
+$0.03 (+1.11%)
Updated
Sep 3 closing price
Capitalization
4.6M
VRAX
Price
$0.60
Change
+$0.03 (+5.26%)
Updated
Sep 3 closing price
Capitalization
2.62M
Interact to see
Advertisement

REVB vs VRAX

Header iconREVB vs VRAX Comparison
Open Charts REVB vs VRAXBanner chart's image
Revelation Biosciences
Price$2.73
Change+$0.03 (+1.11%)
Volume$45.55K
Capitalization4.6M
Virax Biolabs Group
Price$0.60
Change+$0.03 (+5.26%)
Volume$259.6K
Capitalization2.62M
REVB vs VRAX Comparison Chart in %
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. VRAX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a StrongBuy and VRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (REVB: $2.70 vs. VRAX: $0.57)
Brand notoriety: REVB and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 23% vs. VRAX: 23%
Market capitalization -- REVB: $4.6M vs. VRAX: $2.62M
REVB [@Biotechnology] is valued at $4.6M. VRAX’s [@Biotechnology] market capitalization is $2.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, REVB is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 3 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • REVB’s TA Score: 3 bullish, 5 bearish.
  • VRAX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than REVB.

Price Growth

REVB (@Biotechnology) experienced а -3.16% price change this week, while VRAX (@Biotechnology) price change was -9.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REVB($4.6M) has a higher market cap than VRAX($2.62M). VRAX YTD gains are higher at: -74.618 vs. REVB (-87.798). VRAX has higher annual earnings (EBITDA): -6.43M vs. REVB (-8.08M). VRAX has more cash in the bank: 7.29M vs. REVB (5.17M). REVB has less debt than VRAX: REVB (0) vs VRAX (380K). VRAX has higher revenues than REVB: VRAX (84.9K) vs REVB (0).
REVBVRAXREVB / VRAX
Capitalization4.6M2.62M175%
EBITDA-8.08M-6.43M126%
Gain YTD-87.798-74.618118%
P/E Ratio0.00N/A-
Revenue084.9K-
Total Cash5.17M7.29M71%
Total Debt0380K-
TECHNICAL ANALYSIS
Technical Analysis
REVBVRAX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
70%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTO2.740.46
+20.44%
Entero Therapeutics Inc
IRON61.401.75
+2.94%
Disc Medicine
MIND10.270.15
+1.43%
MIND Technology
BLZE8.19-0.16
-1.92%
Backblaze
PAYC220.00-7.15
-3.15%
Paycom Software

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-2.17%
GNPX - REVB
48%
Loosely correlated
-3.54%
INM - REVB
32%
Poorly correlated
-2.70%
GLMD - REVB
31%
Poorly correlated
N/A
NTLA - REVB
31%
Poorly correlated
+0.40%
IMUX - REVB
31%
Poorly correlated
-2.56%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-5.73%
ALZN - VRAX
45%
Loosely correlated
-0.82%
REVB - VRAX
31%
Poorly correlated
-2.17%
RVPH - VRAX
28%
Poorly correlated
+0.67%
BVNKF - VRAX
27%
Poorly correlated
N/A
AURX - VRAX
27%
Poorly correlated
-1.60%
More